drug stringlengths 5 63 | name_type class label 2
classes | sentence stringlengths 58 179 |
|---|---|---|
Abilify | 0brand | We plan to start Abilify at ten milligrams daily to help manage the patient's schizophrenia symptoms effectively. |
Adquey | 0brand | Adquey works as a topical phosphodiesterase-4 inhibitor to help clear lesions associated with mild to moderate atopic dermatitis. |
Advair | 0brand | We are starting the patient on Advair twice daily because combining an inhaled corticosteroid with a LABA will better control her asthma symptoms. |
Advil | 0brand | I recommend taking Advil to help relieve the minor pain from your arthritis, but do not exceed six caplets daily. |
Alhemo | 0brand | We will initiate daily subcutaneous Alhemo to target Tissue Factor Pathway Inhibitor and improve clot formation in this hemophilia patient. |
Alyftrek | 0brand | Before starting Alyftrek, we need to confirm that the patient has at least one responsive CFTR gene variant. |
Ambelvist | 0brand | Before starting the scan, we will administer Ambelvist as an intravenous injection followed immediately by a normal saline flush. |
Ambien | 0brand | Because Ambien functions as a GABA A receptor positive modulator, it should effectively help manage your acute insomnia when taken at bedtime. |
Anktiva | 0brand | We are initiating Anktiva as an intravesical IL-15 receptor agonist alongside BCG for this patient with non-muscle invasive bladder cancer. |
Aspirin | 0brand | I recommend taking this coated Aspirin with plenty of water to help manage your minor aches and pains throughout the day. |
Attruby | 0brand | We should start the patient on Attruby to manage their transthyretin-mediated amyloid cardiomyopathy and reduce the risk of cardiovascular hospitalization. |
Aucatzyl | 0brand | Before we administer the intravenous infusion of Aucatzyl, let's verify that the patient has completed their lymphodepleting chemotherapy regimen. |
Avlayah | 0brand | We should start the pediatric patient on weekly Avlayah infusions to manage Hunter syndrome following the recommended dose escalation schedule. |
Awiqli | 0brand | By activating the insulin receptor, Awiqli effectively stimulates peripheral glucose uptake across the full seven-day dosing interval. |
Baxfendy | 0brand | We can add Baxfendy to your current blood pressure regimen to target aldosterone synthase and better manage your hypertension. |
Benadryl | 0brand | You can administer Benadryl to help relieve your child's sneezing and runny nose caused by upper respiratory allergies. |
Beqalzi | 0brand | Starting the patient on Beqalzi should help trigger apoptosis by selectively targeting the overexpressed BCL-2 protein. |
Biktarvy | 0brand | We can initiate Biktarvy once daily as a complete antiretroviral regimen to effectively manage the patient's HIV-1 infection. |
Bizengri | 0brand | Because the biopsy confirmed an NRG1 fusion, we will initiate Bizengri, which functions as a bispecific antibody targeting HER2 and HER3. |
Blujepa | 0brand | Make sure the patient takes Blujepa with food to treat her uncomplicated urinary tract infection while minimizing gastrointestinal intolerance. |
Byetta | 0brand | We will start Byetta before your two main meals because this GLP-1 receptor agonist helps manage your type 2 diabetes. |
Bysanti | 0brand | We should gradually titrate Bysanti twice daily to help control your manic episodes while minimizing any risk of orthostatic hypotension. |
Casgevy | 0brand | Before we administer the Casgevy infusion, we must complete the patient's full myeloablative conditioning regimen and ensure seizure prophylaxis is in place. |
Chantix | 0brand | We can initiate Chantix as a partial agonist to help curb withdrawal symptoms and support your smoking cessation attempt. |
Claritin | 0brand | You can take Claritin chewable tablets daily to help relieve your sneezing and itchy eyes from seasonal hay fever. |
Cobenfy | 0brand | Before starting Cobenfy for schizophrenia, let's check baseline liver enzymes and ensure the patient takes it on an empty stomach. |
Cosentyx | 0brand | We should start the patient on Cosentyx to selectively inhibit interleukin-17A and manage their active plaque psoriasis. |
Crestor | 0brand | We will start you on Crestor today to inhibit HMG-CoA reductase and significantly lower your LDL-C levels. |
Cymbalta | 0brand | We can start the patient on Cymbalta at thirty milligrams daily to help manage her generalized anxiety disorder. |
Cypsedo | 0brand | We selected Cypsedo for the induction of general anesthesia because of its positive modulation at GABAA receptors. |
Datroway | 0brand | Because Datroway functions as a Trop-2-directed antibody-drug conjugate, we will administer it via intravenous infusion every three weeks. |
Decnupaz | 0brand | We will administer Decnupaz as an intravenous infusion every three weeks to target CD123 in this patient with BPDCN. |
Dupixent | 0brand | We should start Dupixent by subcutaneous injection to target the IL-4Rα subunit and better control your severe asthma. |
Ebglyss | 0brand | We can initiate Ebglyss via subcutaneous injection to specifically target interleukin-13 signaling for this patient with moderate-to-severe atopic dermatitis. |
Eliquis | 0brand | We should start the patient on Eliquis twice daily to reduce their risk of stroke from nonvalvular atrial fibrillation. |
Elrexfio | 0brand | Before administering Elrexfio for multiple myeloma, ensure the patient receives premedications to mitigate the risk of cytokine release syndrome. |
Enbrel | 0brand | We can initiate Enbrel as a weekly subcutaneous injection to help reduce joint inflammation from your rheumatoid arthritis. |
Ensacove | 0brand | Before starting Ensacove for your metastatic NSCLC, we need to check your baseline liver function tests and fasting blood glucose. |
Entresto | 0brand | Let's initiate Entresto today to manage the patient's heart failure by combining a neprilysin inhibitor with an angiotensin receptor blocker. |
Farxiga | 0brand | As an SGLT2 inhibitor, Farxiga works by promoting urinary glucose excretion to help improve glycemic control in type 2 diabetes. |
Flonase | 0brand | Start using two sprays of Flonase in each nostril daily to effectively manage your persistent nasal congestion. |
Foundayo | 0brand | Foundayo is an oral GLP-1 receptor agonist that we will gradually titrate monthly to help regulate your appetite and support weight loss. |
acetaminophen (generic) | 1generic | You can take acetaminophen every six hours to help reduce your fever and relieve minor muscular aches. |
acoltremon (generic) | 1generic | We prescribed TRYPTYR because acoltremon targets ocular TRPM8 thermoreceptors to help stimulate natural basal tear production. |
acoramidis (generic) | 1generic | We should initiate acoramidis for this patient since it functions as a selective stabilizer of transthyretin tetramers. |
adalimumab (generic) | 1generic | Adalimumab works by binding specifically to TNF-alpha to help reduce systemic inflammation and control your rheumatoid arthritis symptoms. |
alprazolam (generic) | 1generic | We can start alprazolam at a low dose to manage your generalized anxiety disorder and slowly titrate if needed. |
apixaban (generic) | 1generic | We are starting the patient on oral apixaban to reduce their risk of stroke associated with nonvalvular atrial fibrillation. |
apremilast (generic) | 1generic | Let's begin oral apremilast today, as its targeted inhibition of phosphodiesterase 4 should help manage your chronic symptoms. |
aripiprazole (generic) | 1generic | Because aripiprazole acts as a partial agonist at D2 receptors, we should start this patient with schizophrenia at ten milligrams daily. |
atacicept-vymj (generic) | 1generic | By dual-targeting BAFF and APRIL, atacicept-vymj effectively lowers pathogenic galactose-deficient IgA1 levels in patients with IgAN. |
atogepant (generic) | 1generic | Starting the patient on atogepant is appropriate because this calcitonin gene-related peptide receptor antagonist effectively reduces migraine frequency. |
atorvastatin (generic) | 1generic | We should start the patient on daily oral atorvastatin to inhibit HMG-CoA reductase and effectively lower their elevated LDL-C levels. |
baloxavir marboxil (generic) | 1generic | We chose baloxavir marboxil for this patient because it halts influenza virus replication by targeting the viral endonuclease activity. |
baxdrostat (generic) | 1generic | We are initiating baxdrostat to selectively target aldosterone synthase and achieve better blood pressure control. |
bevacizumab-vikg (generic) | 1generic | We are initiating bevacizumab-vikg therapy today to inhibit retinal neovascularization and help stabilize the patient's visual acuity. |
bictegravir, emtricitabine, and tenofovir alafenamide (generic) | 1generic | Your doctor has prescribed bictegravir, emtricitabine, and tenofovir alafenamide for your condition. |
budesonide and formoterol fumarate dihydrate (generic) | 1generic | I recommend starting budesonide and formoterol fumarate dihydrate twice daily to provide both anti-inflammatory control and bronchodilation for your asthma. |
bulevirtide-gmod (generic) | 1generic | We plan to start the patient on bulevirtide-gmod today, as this antiviral drug will help target their viral infection. |
canakinumab (generic) | 1generic | We are starting the patient on canakinumab to selectively neutralize IL-1β and suppress their systemic inflammatory response. |
cariprazine (generic) | 1generic | We chose cariprazine for this patient because its partial agonist activity at dopamine D2 receptors helps manage psychiatric symptoms effectively. |
cefepime and zidebactam (generic) | 1generic | Let's initiate cefepime and zidebactam because the addition of a beta-lactamase inhibitor will help overcome this resistant Gram-negative infection. |
centanafadine (generic) | 1generic | We can trial centanafadine for this adult's ADHD since its mechanism involves inhibiting norepinephrine, dopamine, and serotonin reuptake transporters. |
cetirizine (generic) | 1generic | You can take cetirizine once daily to help control your runny nose and sneezing caused by seasonal hay fever. |
cipepofol (generic) | 1generic | We selected Cypsedo for general anesthesia induction because cipepofol enhances inhibitory signaling at GABAA receptors. |
clopidogrel (generic) | 1generic | We should start clopidogrel immediately with a loading dose to inhibit platelet aggregation in this acute coronary syndrome patient. |
concizumab (generic) | 1generic | We are starting the patient on concizumab because targeting tissue factor pathway inhibitor helps manage their hemophilia despite existing inhibitors. |
copper histidinate (generic) | 1generic | We should initiate daily subcutaneous copper histidinate injections to bypass impaired absorption and treat the infant with Menkes disease. |
dapagliflozin (generic) | 1generic | We can start dapagliflozin at five milligrams daily to improve glycemic control by blocking glucose reabsorption in the proximal renal tubules. |
datopotamab deruxtecan (generic) | 1generic | We plan to start datopotamab deruxtecan today since this novel antibody-drug conjugate effectively delivers a potent topoisomerase I inhibitor to tumors. |
diazepam (generic) | 1generic | We should start oral diazepam to help manage this patient's acute alcohol withdrawal symptoms and reduce the risk of delirium tremens. |
difamilast (generic) | 1generic | Applying difamilast works by inhibiting phosphodiesterase-4, which elevates intracellular cyclic AMP levels to suppress inflammatory signaling. |
dimethyl fumarate (generic) | 1generic | We plan to start oral dimethyl fumarate to help reduce relapses and manage your multiple sclerosis symptoms. |
diphenhydramine (generic) | 1generic | Let's administer fifty milligrams of diphenhydramine intravenously as an adjunct to epinephrine following the patient's acute anaphylaxis. |
doravirine and islatravir (generic) | 1generic | We can switch the patient to doravirine and islatravir to effectively suppress HIV-1 replication with this novel antiretroviral combination regimen. |
dulaglutide (generic) | 1generic | Because dulaglutide acts as a GLP-1 receptor agonist, it effectively stimulates glucose-dependent insulin release from pancreatic beta cells. |
duloxetine (generic) | 1generic | We can initiate oral duloxetine at thirty milligrams daily to help manage your chronic musculoskeletal pain while minimizing potential side effects. |
dupilumab (generic) | 1generic | We are starting dupilumab to target the IL-4Rα subunit and reduce the patient's recurring airway inflammation. |
durvalumab (generic) | 1generic | We are starting the patient on durvalumab, a monoclonal antibody that targets PD-L1 to restore cytotoxic T-cell activity against the tumor. |
efgartigimod alfa (generic) | 1generic | Because efgartigimod alfa targets the neonatal Fc receptor, we should monitor the patient for a significant reduction in circulating IgG levels. |
elexacaftor, tezacaftor, and ivacaftor (generic) | 1generic | Starting elexacaftor, tezacaftor, and ivacaftor will help facilitate CFTR protein trafficking and restore essential chloride transport. |
elranatamab-bcmm (generic) | 1generic | We are starting elranatamab-bcmm today to target BCMA and induce T-cell mediated lysis of refractory multiple myeloma cells. |
empagliflozin (generic) | 1generic | Starting empagliflozin will selectively block SGLT2 transporters in the kidneys, which directly promotes urinary glucose excretion. |
enlicitide decanoate (generic) | 1generic | We can initiate enlicitide decanoate to target PCSK9 and help lower your circulating low-density lipoprotein levels effectively. |
ensartinib (generic) | 1generic | We should consider ensartinib for this patient because it effectively targets anaplastic lymphoma kinase and blocks downstream tumor proliferation. |
ensitrelvir (generic) | 1generic | We are starting ensitrelvir to target the SARS-CoV-2 main protease and stop active viral replication in this patient. |
esomeprazole (generic) | 1generic | We will start esomeprazole once daily to inhibit the H+/K+ ATPase enzyme system and relieve your symptomatic GERD. |
etanercept (generic) | 1generic | We should start the patient on etanercept today to help block TNF and reduce the severe joint inflammation. |
exagamglogene autotemcel (generic) | 1generic | We plan to administer exagamglogene autotemcel to suppress BCL11A expression and prevent painful vaso-occlusive crises in our sickle cell patient. |
exenatide (generic) | 1generic | As a GLP-1 receptor agonist, exenatide enhances glucose-dependent insulin secretion to improve blood sugar levels in type 2 diabetes. |
famotidine (generic) | 1generic | We can start you on oral famotidine at bedtime to competitively inhibit histamine-2 receptors and reduce gastric acid secretion. |
faricimab-svoa (generic) | 1generic | We chose faricimab-svoa because this bispecific antibody simultaneously targets VEGF-A and Ang-2 to help reduce vascular permeability. |
fezolinetant (generic) | 1generic | We can initiate fezolinetant today because this neurokinin 3 receptor antagonist effectively targets neuronal activity in the thermoregulatory center. |
fluoxetine (generic) | 1generic | We will start the patient on oral fluoxetine every morning to effectively manage their ongoing major depressive disorder. |
fluticasone propionate (generic) | 1generic | You can use fluticasone propionate once daily in each nostril to relieve stubborn nasal congestion caused by your allergies. |
fluticasone propionate and salmeterol (generic) | 1generic | We are starting fluticasone propionate and salmeterol twice daily to control persistent airway inflammation and relax bronchial smooth muscle. |
gadoquatrane (generic) | 1generic | Administering gadoquatrane enhances tissue signal intensity during the scan by effectively altering the relaxation rates of local water protons. |
gedatolisib (generic) | 1generic | Adding gedatolisib helps target both PI3K and mTOR complexes to slow tumor growth in ER-positive breast cancer. |
gepotidacin (generic) | 1generic | We can initiate gepotidacin for this patient once we confirm the bacterial source of the infection. |
ibuprofen (generic) | 1generic | You can take ibuprofen every four to six hours to help relieve the pain caused by your menstrual cramps. |
DOSE v1.0: Drug-name Oral Synthesis Evaluation
Can your voice model say retatrutide?
DOSE is a benchmark measuring how accurately text-to-speech (TTS) systems pronounce pharmaceutical drug names. It covers established brands, newly-approved names, and generic/INN names, each tested inside a real clinical sentence rather than spoken in isolation.
Version: DOSE v1.0. Live leaderboard and five public audio samples: https://synthiolabs.com/synthio-dose-benchmark
This public dataset is the held-out test set only: drug name, name type, and clinical sentence. Reference pronunciations, evaluation audio, and per-system scores are not released, so the set cannot be used as an answer key. Email rohit@synthiolabs.com to submit a model for scoring.
Why this matters
Mispronounced drug names in voice AI (IVR systems, clinical voice agents, pharmacy assistants) are a patient-safety concern analogous to LASA (Look-Alike/Sound-Alike) drug name confusion — a recognized WHO/ISMP/FDA error category. As voice AI is deployed further into clinical workflows, TTS mispronunciation of a drug name is a new, largely unmeasured extension of that same risk category.
Quickstart
from datasets import load_dataset
ds = load_dataset("SynthioLabs/dose-benchmark", split="train")
row = ds[0]
print(row["drug"], row["name_type"], row["sentence"])
Filter by name type:
generic_names = ds.filter(lambda r: r["name_type"] == "generic")
brand_names = ds.filter(lambda r: r["name_type"] == "brand")
Dataset
- 274 drug names: 128 traditional (established) + 146 new (recently approved) names. One row per name.
- Brand and generic/INN names (
name_typecolumn). - 9 TTS systems were evaluated on these sentences (see leaderboard). Those recordings and scores are not in this download.
- Every system read the exact same clinical sentence containing the drug name, with no special pronunciation hints given to any system.
How DOSE is scored
Reference pronunciations. Each drug’s reference comes from public pharmaceutical sources, including labels, manufacturer materials, and established medical references. It is then checked against spoken clinical usage so the target reflects the accepted pronunciation — not a model’s guess. The reference strings themselves are held out.
Judge. Each system’s recording is scored 0–5 against that same reference by automated audio comparison. Several independent judgments are combined into one result; 4 or higher counts as a pass. Human reviewers are not in the scoring loop.
Columns
| Column | Type | Description |
|---|---|---|
drug |
string | Drug name (brand or generic/INN) |
name_type |
class label | brand or generic |
sentence |
string | The clinical sentence to be read aloud |
Leaderboard (overall pass rate, score >= 4)
| Rank | System | Model | Pass rate |
|---|---|---|---|
| 1 | Synthio | Synthio RxPronounce | 91.2% |
| 2 | Cartesia | sonic-3.6 (beta) | 80.3% |
| 3 | ElevenLabs | eleven_v3 | 79.2% |
| 4 | OpenAI TTS | gpt-4o-mini-tts | 77.4% |
| 5 | xAI | Grok TTS | 77.0% |
| 6 | Google (Gemini TTS) | gemini-3.1-flash-tts-preview | 74.5% |
| 7 | Deepgram | aura-2-thalia-en | 72.6% |
| 8 | Cartesia | sonic-3.5 | 69.0% |
| 9 | Microsoft Azure | DragonHD Neural | 63.1% |
Submit your model
Email us at rohit@synthiolabs.com to submit a model for evaluation.
Citation
@misc{synthio2026dosev1,
title = {DOSE v1.0: Drug-name Oral Synthesis Evaluation},
author = {Pari, Rohit Gangadhar and {Synthio Labs}},
year = {2026},
url = {https://synthiolabs.com/synthio-dose-benchmark}
}
- Downloads last month
- 39